HYPERION DEFI, INC. Stock-Based Compensation
HYPERION DEFI, INC. (HYPD) reported Stock-Based Compensation of $3.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.63M, a 71.23% decline year-over-year.
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.80M, a 545.32% increase year-over-year.
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $5.67M, a 948.63% increase year-over-year.
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $279.63K, a 48.81% decline year-over-year.
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $6.37M, a 273.88% increase from fiscal 2024.
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.70M, a 31.77% decline from fiscal 2023.
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $2.50M, a 33.66% decline from fiscal 2022.
- HYPERION DEFI, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $3.77M, a 30.47% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.44M 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $1.80M 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $6.37M 10-K · filed 2026-03-30 | |||
| 2025-06-30 | $5.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.95M 10-Q · filed 2026-08-13 | $6.12M derived: sum of 3 quarters · filed 2026-08-13 | $6.57M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $279.63K 10-Q · filed 2026-05-15 | $443.62K derived: sum of 2 quarters · filed 2026-05-15 | $896.61K derived: sum of 3 quarters · filed 2026-05-15 | $1.44M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $163.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $616.99K derived: sum of 2 quarters · filed 2026-03-30 | $1.16M derived: sum of 3 quarters · filed 2026-03-30 | $1.70M 10-K · filed 2026-03-30 |
| 2024-09-30 | $453.00K 10-Q · filed 2024-11-12 | $994.05K derived: sum of 2 quarters · filed 2024-11-12 | $1.54M 10-Q · filed 2024-11-12 | $2.11M derived: sum of 4 quarters · filed 2025-05-19 |
| 2024-06-30 | $541.06K 10-Q · filed 2024-08-14 | $1.09M 10-Q · filed 2024-08-14 | $1.66M derived: sum of 3 quarters · filed 2025-05-19 | $2.27M derived: sum of 4 quarters · filed 2025-05-19 |
| 2024-03-31 | $546.23K 10-Q · filed 2025-05-19 | $1.12M derived: sum of 2 quarters · filed 2025-05-19 | $1.73M derived: sum of 3 quarters · filed 2025-05-19 | $2.23M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $572.23K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $1.19M derived: sum of 2 quarters · filed 2025-04-15 | $1.68M derived: sum of 3 quarters · filed 2025-04-15 | $2.50M 10-K · filed 2025-04-15 |
| 2023-09-30 | $612.97K 10-Q · filed 2024-11-12 | $1.11M derived: sum of 2 quarters · filed 2024-11-12 | $1.93M 10-Q · filed 2024-11-12 | $2.82M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $493.63K 10-Q · filed 2024-08-14 | $1.31M 10-Q · filed 2024-08-14 | $2.20M derived: sum of 3 quarters · filed 2024-08-14 | $3.13M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $819.06K 10-Q · filed 2024-05-15 | $1.71M derived: sum of 2 quarters · filed 2024-05-15 | $2.64M derived: sum of 3 quarters · filed 2024-05-15 | $3.68M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $890.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.82M derived: sum of 2 quarters · filed 2024-03-18 | $2.86M derived: sum of 3 quarters · filed 2024-03-18 | $3.77M 10-K · filed 2024-03-18 |
| 2022-09-30 | $928.73K 10-Q · filed 2023-11-13 | $1.97M derived: sum of 2 quarters · filed 2023-11-13 | $2.87M 10-Q · filed 2023-11-13 | $3.69M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.04M 10-Q · filed 2023-08-11 | $1.95M 10-Q · filed 2023-08-11 | $2.76M derived: sum of 3 quarters · filed 2023-08-11 | $3.54M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $908.99K 10-Q · filed 2023-05-12 | $1.72M derived: sum of 2 quarters · filed 2023-05-12 | $2.50M derived: sum of 3 quarters · filed 2023-05-12 | $3.14M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $814.37K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.59M derived: sum of 2 quarters · filed 2023-03-31 | $2.23M derived: sum of 3 quarters · filed 2023-03-31 | $2.89M 10-K · filed 2023-03-31 |
| 2021-09-30 | $777.47K 10-Q · filed 2022-11-14 | $1.41M derived: sum of 2 quarters · filed 2022-11-14 | $2.07M 10-Q · filed 2022-11-14 | $2.73M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $637.36K 10-Q · filed 2022-08-11 | $1.29M 10-Q · filed 2022-08-11 | $1.95M derived: sum of 3 quarters · filed 2022-08-11 | $2.56M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $656.91K 10-Q · filed 2022-05-13 | $1.31M derived: sum of 2 quarters · filed 2022-05-13 | $1.92M derived: sum of 3 quarters · filed 2022-05-13 | $2.56M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $656.23K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.27M derived: sum of 2 quarters · filed 2022-03-30 | $1.90M derived: sum of 3 quarters · filed 2022-03-30 | $2.48M 10-K · filed 2022-03-30 |
| 2020-09-30 | $609.93K 10-Q · filed 2020-11-12 | $1.24M derived: sum of 2 quarters · filed 2020-11-12 | $1.83M 10-Q · filed 2021-11-12 | $2.41M derived: sum of 4 quarters · filed 2021-05-14 |
| 2020-06-30 | $633.15K 10-Q · filed 2020-08-14 | $1.22M 10-Q · filed 2021-08-12 | $1.80M derived: sum of 3 quarters · filed 2021-05-14 | $2.27M derived: sum of 4 quarters · filed 2021-05-14 |
| 2020-03-31 | $583.87K 10-Q · filed 2021-05-14 | $1.16M derived: sum of 2 quarters · filed 2021-05-14 | $1.64M derived: sum of 3 quarters · filed 2021-05-14 | $2.06M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $578.12K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $1.05M derived: sum of 2 quarters · filed 2021-03-30 | $1.48M derived: sum of 3 quarters · filed 2021-03-30 | $2.51M 10-K · filed 2021-03-30 |
| 2019-09-30 | $476.84K 10-Q · filed 2020-11-12 | $900.86K derived: sum of 2 quarters · filed 2020-11-12 | $1.93M 10-Q · filed 2020-11-12 | $2.43M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $424.02K 10-Q · filed 2020-08-14 | $1.46M 10-Q · filed 2020-08-14 | $1.96M derived: sum of 3 quarters · filed 2020-08-14 | $2.42M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $1.03M 10-Q · filed 2020-05-14 | $1.53M derived: sum of 2 quarters · filed 2020-05-14 | $2.00M derived: sum of 3 quarters · filed 2020-05-14 | $2.00M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $500.44K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $963.38K derived: sum of 2 quarters · filed 2020-03-30 | $964.89K derived: sum of 3 quarters · filed 2020-03-30 | $1.62M 10-K · filed 2020-03-30 |
| 2018-09-30 | $462.94K 10-Q · filed 2019-11-13 | $464.46K derived: sum of 2 quarters · filed 2019-11-13 | $1.12M 10-Q · filed 2019-11-13 | $1.31M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $1.51K 10-Q · filed 2019-08-13 | $652.09K 10-Q · filed 2019-08-13 | $851.99K derived: sum of 3 quarters · filed 2019-08-13 | $1.06M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $650.58K 10-Q · filed 2019-05-14 | $850.48K derived: sum of 2 quarters · filed 2019-05-14 | $1.06M derived: sum of 3 quarters · filed 2019-05-14 | $1.06M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $199.90K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $405.92K derived: sum of 2 quarters · filed 2019-03-27 | $408.98K derived: sum of 3 quarters · filed 2019-03-27 | $412.31K 10-K · filed 2019-03-27 |
| 2017-09-30 | $206.02K 10-Q · filed 2018-11-13 | $209.07K derived: sum of 2 quarters · filed 2018-11-13 | $212.41K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $3.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $6.39K 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $3.34K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $2.69K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |